Baxter International Inc. vs. Bioventus Inc. Class A Common Stock
BAX
Baxter International Inc.
$26.73 -1.18%
VS BVSBioventus Inc. Class A Common Stock
$14.26 +2.66%
Baxter International Inc. and Bioventus Inc. Class A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BAX | BVS | |
|---|---|---|
| Market Cap | $13.82 billion | $1.20 billion |
| Revenue (TTM) | $11.47 billion | $581.85 million |
| Net Income (TTM) | $-1,063,000,000 | $61.48 million |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | BVS | |
|---|---|---|
| P/E Ratio | — | 18.52 |
| Price / Book | 2.24 | 4.32 |
| Price / Sales | 1.20 | 2.06 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | BVS | |
|---|---|---|
| Net Margin | -9.27% | 10.57% |
| Return on Equity | -17.20% | 22.16% |
BVS leads on 2 of 2 profitability factors.
Dividend
| BAX | BVS | |
|---|---|---|
| Dividend Yield | 0.15% | — |
BAX and BVS split the dividend factors evenly.
Risk & Sentiment
| BAX | BVS | |
|---|---|---|
| Short Interest | 1.03% | 0.78% |
BVS leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, BVS overview, BVS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.